Mirtazapine 2 mg/ml Oral Liquid is a specially compounded medication designed for oral use, offering a precise and manageable method of drug delivery. This liquid formulation is particularly beneficial for patients who experience difficulty swallowing pills, such as those in pediatric and geriatric groups. Mirtazapine is commonly used to treat major depressive disorder, providing relief from symptoms such as sadness, loss of interest in activities, and sleep disturbances. Additionally, it may be prescribed off-label for conditions like anxiety disorders and to stimulate appetite in individuals with medical conditions that suppress hunger.

Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
Mirtazapine 2 mg/ml Oral Liquid is a specially compounded medication designed for ease of administration and precise dosing. This formulation is particularly beneficial for patients who experience difficulty swallowing tablets or capsules, such as those in pediatric and geriatric populations. The liquid form allows for flexible dosing, which can be adjusted according to the specific needs of the patient. Mirtazapine is an antidepressant that belongs to a class of medications known as noradrenergic and specific serotonergic antidepressants (NaSSAs). It works by balancing neurotransmitters in the brain, which helps to improve mood and alleviate symptoms of depression.
The oral liquid formulation of Mirtazapine is used to treat major depressive disorder (MDD), a condition characterized by persistent feelings of sadness and a lack of interest in life that can interfere with daily functioning. Mirtazapine may also be used off-label for other conditions as determined by a healthcare provider. It is important to note that the onset of antidepressant action typically takes several weeks, and patients are advised to continue taking the medication as prescribed, even if they feel better, to maintain its therapeutic benefits.
For prescribers, it is crucial to tailor the dose of Mirtazapine 2 mg/ml Oral Liquid to the individual patient's requirements, starting with a lower dose and gradually increasing as needed while monitoring for efficacy and tolerability. The liquid formulation allows for such titration with greater precision than fixed-dose tablets. Patients should be monitored for common side effects, which may include drowsiness, increased appetite, weight gain, and dry mouth. More serious side effects should be reported to a healthcare provider immediately.
Bayview Pharmacy is committed to providing high-quality, customized medications to meet the unique needs of each patient. Our team of knowledgeable compounding pharmacists is available to answer any questions and provide guidance on the use of Mirtazapine 2 mg/ml Oral Liquid. We work closely with prescribers to ensure optimal therapeutic outcomes for our patients. If you have any questions or require further information about this formulation, please do not hesitate to reach out to us.
Mirtazapine is an antidepressant that works by modulating central noradrenergic and serotonergic activity, which is thought to enhance its antidepressant effects. While mirtazapine is generally well-tolerated, it can interact with a variety of medications, which may alter its effectiveness or increase the risk of adverse effects. It is important for both patients and prescribers to be aware of these potential interactions when considering the use of mirtazapine 2 mg/ml oral liquid.
One significant interaction is with central nervous system (CNS) depressants, such as benzodiazepines, opioids, antihistamines, and alcohol. Concurrent use of these substances with mirtazapine can enhance sedation and increase the risk of respiratory depression, which can be particularly dangerous. Patients should be advised to avoid or limit the use of alcohol and to use other CNS depressants with caution while taking mirtazapine.
Another important interaction is with monoamine oxidase inhibitors (MAOIs). The use of mirtazapine in combination with MAOIs or within 14 days of discontinuing treatment with an MAOI is contraindicated due to the risk of serotonin syndrome, a potentially life-threatening condition. Symptoms of serotonin syndrome may include confusion, hallucination, seizure, extreme changes in blood pressure, increased heart rate, fever, excessive sweating, shivering or shaking, blurred vision, muscle spasm or stiffness, tremor, incoordination, stomach cramp, nausea, vomiting, and diarrhea.
Additionally, mirtazapine may interact with other serotonergic drugs, such as selective serotonin reuptake inhibitors (SSRIs), serotonin-norepinephrine reuptake inhibitors (SNRIs), and triptans, among others. This can also increase the risk of serotonin syndrome. Prescribers should monitor patients closely, especially during initiation and dose changes, for symptoms of serotonin syndrome.
Warfarin and other anticoagulants may also interact with mirtazapine. Mirtazapine can displace warfarin from protein binding sites, potentially leading to an increased risk of bleeding. Patients on anticoagulant therapy should be closely monitored for changes in prothrombin time or INR when initiating or changing the dose of mirtazapine.
Cytochrome P450 (CYP) enzyme inducers, such as carbamazepine and phenytoin, or inhibitors, such as ketoconazole and cimetidine, can affect the metabolism of mirtazapine. This may necessitate dosage adjustments of mirtazapine to maintain therapeutic effectiveness or to avoid toxicity.
It is also important to note that mirtazapine may cause orthostatic hypotension, particularly when combined with other medications that lower blood pressure. Patients should be counseled on the signs and symptoms of low blood pressure and advised to rise slowly from sitting or lying positions.
Lastly, mirtazapine is used to treat major depressive disorder and other mood disorders. It may improve mood, feelings of well-being, sleep, appetite, and energy level. However, the full range of its effects and interactions is not limited to the above, and prescribers should consult the full prescribing information for a more comprehensive understanding of potential drug interactions.
If you have any questions or require further information regarding the use of mirtazapine 2 mg/ml oral liquid, please do not hesitate to reach out to us at Bayview Pharmacy. Our team of compounding pharmacists is here to provide support and guidance to support the safe and appropriate medication management for our patients.
Mirtazapine is an antidepressant medication that works by balancing neurotransmitters in the brain. It is particularly known for its action on serotonin and norepinephrine, which are chemicals that help regulate mood. When these neurotransmitters are out of balance, symptoms of depression can occur. Mirtazapine helps to restore the balance of these chemicals, which can improve mood and relieve depression. The 2 mg/ml oral liquid formulation of mirtazapine has been specifically designed to provide a lower dose of the medication in a form that is easy to ingest, making it ideal for patients who have difficulty swallowing pills, such as children and the elderly, or for those who require precise dosing that may not be achievable with solid dosage forms.
The mirtazapine oral liquid is absorbed through the gastrointestinal tract after ingestion. Once absorbed, it crosses the blood-brain barrier and exerts its effects on the central nervous system. The liquid formulation allows for the medication to be absorbed more quickly than a tablet or capsule, which can be beneficial for patients who need rapid onset of action. Additionally, the liquid form allows for flexible dosing, which is particularly useful for titrating the dose to the individual needs of the patient, ensuring that the minimum effective dose is used to reduce the risk of side effects.
Mirtazapine is used to treat major depressive disorder (MDD) and other mood disorders. It can help alleviate symptoms such as sadness, loss of interest in activities, sleep disturbances, and anxiety. It is also sometimes used off-label for conditions such as insomnia and anxiety disorders due to its sedative effects. The oral liquid formulation can be particularly useful for patients who are sensitive to medication changes or who require a slow and controlled adjustment of their dosage.
Consistent use as directed by a healthcare professional is crucial for the medication to work properly. Additionally, patients should be monitored for any side effects and for improvements in their symptoms to ensure that the medication is working as intended.
If you have any questions about the mirtazapine 2 mg/ml oral liquid formulation or its use in treating depression and other conditions, please reach out to us at Bayview Pharmacy. Our team of compounding pharmacists is here to provide you with the information and support you need to effectively manage your health or the health of your patients.
Mirtazapine 2 mg/ml Oral Liquid is a specially prepared form of the antidepressant medication Mirtazapine. This liquid formulation is designed for oral use and is particularly suitable when difficulty in swallowing solid forms exists, such as in pediatric or geriatric patients.
Store Mirtazapine Oral Liquid at room temperature, away from direct sunlight and moisture. Keep the bottle tightly closed and out of reach of children. Do not freeze the medication, and be aware of the expiration date on the label.
Take Mirtazapine Oral Liquid as directed by your healthcare provider. Use the provided measuring device to ensure the accurate dosage, and swallow the liquid medication directly. It may be taken with or without food. Do not mix with other liquids unless specifically directed by your healthcare provider.
If you miss a dose of Mirtazapine Oral Liquid, take it as soon as you remember. However, if it's almost time for your next scheduled dose, skip the missed dose and continue with your regular dosing schedule. Do not take a double dose to make up for a missed one.
Yes, Mirtazapine Oral Liquid can be used for children when prescribed by a healthcare provider. The liquid form is often favored for pediatric use due to its ease of administration and the ability to tailor the dosage to the child's specific needs.
No, there is generally no difference in the effectiveness of Mirtazapine whether it's administered in liquid or tablet form. Both formulations are absorbed into the body and work in the same way. The primary difference lies in the mode of administration.
No, you should not stop taking Mirtazapine Oral Liquid abruptly even if you feel better. Stopping the medication suddenly may cause withdrawal symptoms or your original symptoms could return. Always talk to your healthcare provider before making any changes to how you take your medication.
While taking Mirtazapine Oral Liquid, you may need to avoid alcohol as it can intensify some of the side effects such as drowsiness and impaired motor function. Other restrictions will be advised by your healthcare provider based on your condition and treatment plan.
If you take more Mirtazapine Oral Liquid than prescribed, seek immediate medical attention. Overdose can be serious and may require immediate treatment.
Yes, like all medications, Mirtazapine Oral Liquid can cause side effects. Some common ones include drowsiness, increased appetite, weight gain, and dry mouth. If you experience any severe or persistent side effects, contact your healthcare provider.
Use the measuring device that comes with the medication for an accurate dose. Do not use a regular household spoon as this may not provide an accurate measurement. If you have any questions about measuring your dose, consult with your healthcare provider or pharmacist.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice. Discuss your situation with a licensed healthcare provider.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
Take orally